ARCHIVES

In Brief: Pursell Most Likely To Replace Conte, Foriend Of Cancer Program; DeVita Names Associate

This article is from The Cancer Letter archive.

Vol. 17 No. 07 | February 15, 1991

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

Canadian Responds To Criticism Of Study, Says Results Not ‘Politically Correct’

November 27, 1992

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

Newell Reports Cancer Deaths In Younger Age Groups Dropping

March 18, 1977